We are live on
!
Find out more
CS
Candriam SCA Portfolio holdings
AUM
$19.3B
1-Year Est. Return
39.18%
This Fund
S&P 500
This Quarter
Est. Return
+4.06%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$8.02B
AUM Growth
+$201M
(+2.6%)
Cap. Flow
-$89M
Cap. Flow
% of AUM
-1.11%
Top 10 Holdings %
Top 10 Hldgs %
19.81%
Holding
867
New
76
Increased
308
Reduced
302
Closed
63
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$48.8M |
| 2 |
Procter & Gamble
PG
|
+$24.6M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$23.6M |
| 4 |
Keysight
KEYS
|
+$23.2M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$21.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$46.5M |
| 2 |
ExxonMobil
XOM
|
+$36.6M |
| 3 |
GG
Goldcorp Inc
GG
|
+$24.9M |
| 4 |
Walt Disney
DIS
|
+$23.8M |
| 5 |
NAVG
Navigators Group Inc
NAVG
|
+$19.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 33.16% |
| 2 | Technology | 16.87% |
| 3 | Financials | 10.38% |
| 4 | Consumer Discretionary | 9.09% |
| 5 | Communication Services | 7.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Supernus Pharmaceuticals
SUPN
$2.68B
| $9.39M | 0.12% |
285,000
+75,000
| +36% | +$2.57M |
|
|
PARA
202
DELISTED
Paramount Global Class B
PARA
| $9.3M | 0.12% |
187,201
-30,204
| -14% | -$1.5M |
|
203
Galicia Financial Group
GGAL
$7.92B
| $9.26M | 0.12% |
262,000
-71,000
| -21% | -$1.9M |
|
204
Boeing
BA
$165B
| $9.2M | 0.11% |
25,380
-3,293
| -11% | -$1.2M |
|
|
SPPI
205
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $9.15M | 0.11% |
1,067,400
+22,500
| +2% | +$201K |
|
206
Akamai
AKAM
$16.8B
| $9.1M | 0.11% |
114,091
+773
| +0.7% | +$59.8K |
|
207
Eversource Energy
ES
$28.2B
| $8.81M | 0.11% |
104,790
+16,574
| +19% | +$1.21M |
|
|
GWPH
208
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $8.79M | 0.11% |
51,200
+10,000
| +24% | +$1.73M |
|
|
OAK
209
DELISTED
OAKTREE CAPITAL GROUP, LLC
OAK
| $8.78M | 0.11% |
177,998
+120,981
| +212% | +$5.99M |
|
210
Trex
TREX
$4.51B
| $8.7M | 0.11% |
+243,712
| New | +$8.26M |
|
211
Williams Companies
WMB
$90.5B
| $8.67M | 0.11% |
310,591
+122,827
| +65% | +$3.41M |
|
212
Entergy
ETR
$54.1B
| $8.61M | 0.11% |
168,104
+52,308
| +45% | +$2.55M |
|
213
Ambarella
AMBA
$2.99B
| $8.57M | 0.11% |
194,959
-55,024
| -22% | -$2.47M |
|
214
Carnival Corporation Ltd
CCL
$36.1B
| $8.56M | 0.11% |
184,807
-35,619
| -16% | -$1.86M |
|
|
CTXS
215
DELISTED
Citrix Systems Inc
CTXS
| $8.52M | 0.11% |
78,186
-18,762
| -19% | -$1.84M |
|
216
CenterPoint Energy
CNP
$29.1B
| $8.5M | 0.11% |
257,187
-114,614
| -31% | -$3.42M |
|
217
Wayfair
W
$11.1B
| $8.47M | 0.11% |
+3,787
| New | +$570K |
|
218
Prologis
PLD
$138B
| $8.37M | 0.1% |
105,008
+5,769
| +6% | +$439K |
|
219
Synchrony
SYF
$23.7B
| $8.37M | 0.1% |
242,456
-66,170
| -21% | -$2.24M |
|
220
US Bancorp
USB
$99.6B
| $8.29M | 0.1% |
132,723
-13,398
| -9% | -$690K |
|
221
Citizens Financial Group
CFG
$30.4B
| $8.26M | 0.1% |
234,596
-44,119
| -16% | -$1.54M |
|
222
PACCAR
PCAR
$69.6B
| $8.26M | 0.1% |
173,624
-202,509
| -54% | -$9.41M |
|
223
CEVA Inc
CEVA
$1.01B
| $8.18M | 0.1% |
337,199
+37,415
| +12% | +$919K |
|
|
MDCO
224
DELISTED
Medicines Co
MDCO
| $8.04M | 0.1% |
221,500
+85,000
| +62% | +$2.77M |
|
225
Micron Technology
MU
$1.04T
| $8.04M | 0.1% |
176,205
-8,224
| -4% | -$313K |
|
Similar funds
PCM
A
MGP
LF
SOMRS
BPA
MIM
Candriam SCA's Q2 2019 Portfolio in Review
As of Q2 2019, Candriam SCA held 867 positions worth $8.02B, up 2.6% from $7.82B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Candriam SCA's Q2 2019 filing shows 76 new, 308 increased, 302 reduced and 63 closed positions. Its largest new stake was Total System Services, Inc.: 112,342 shares worth $14.3M. The largest sale was Celgene Corp, an estimated $46.5M.
By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 33% a quarter earlier, followed by Technology and Financials.
- Candriam SCA's largest Q2 2019 buy was Total System Services, Inc.: 112,342 shares worth $14.3M.
- Candriam SCA added most to Vertex Pharmaceuticals in Q2 2019, an estimated $48.8M increase.
- Candriam SCA's biggest Q2 2019 reduction was Celgene Corp, cutting an estimated $46.5M.
- Candriam SCA fully exited Goldcorp Inc in Q2 2019, selling an estimated $24.9M.
- Candriam SCA's ten largest holdings make up 20% of its $8.02B portfolio in Q2 2019.
- Candriam SCA opened 76 new positions and closed 63 in Q2 2019.
- Candriam SCA's portfolio value rose 2.6% quarter-over-quarter to $8.02B.
Based on Candriam SCA's 13F filing for Q2 2019, filed 1 Aug 2019.